Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Xolremdi (mavorixafor)
.
Show all posts
Showing posts with label
Xolremdi (mavorixafor)
.
Show all posts
Tuesday, September 10, 2024
FDA Approves Xolremdi (mavorixafor) for Use in Patients with WHIM Syndrome
›
X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced ...
›
Home
View web version
